ResMed | RMD - Gross Profit On Sales


ResMed reported $861.22M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Ansell USD 326.2M 27.6M Jun/2024
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Baxter International USD 1.14B 251M Jun/2026
Cochlear AUD 856.8M 430M Dec/2025
Cooper Companies USD 735.4M 40.2M Mar/2026
CSL USD 4.46B 2.71B Dec/2025
Dexcom USD 750.3M 42.4M Mar/2026
Edwards Lifesciences USD 1.35B 62.6M Jun/2026
Fisher Paykel Healthcare NZD 784.4M 98.7M Jun/2026
Globus Medical USD 548.17M 51.91M Jun/2026
Haemonetics USD 202.8M 4.59M Jun/2026
Idexx Laboratories USD 779.09M 56.35M Jun/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 562.6M 21.8M Jun/2026
Integra LifeSciences USD 215.97M 2.77M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
Medtronic USD 6.01B 595M Mar/2026
Philips EUR 2.15B 384M Jun/2026
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 861.22M 29.76M Jun/2026
Sigma Healthcare AUD 160.13M 10.55M Jul/2024
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Steris USD 684.2M 12.9M Jun/2026
Teleflex USD 331.71M 24.28M Jun/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026